Wow, check this out! Congratulations to @Maimon_roni and @GeorgiaMNeuro for securing third and second place for their outstanding oral presentations at #CVRS2023! 🎉

A bit late, but we need to highlight the outstanding keynote delivered by @TesDekker, honoring the remarkable life and contributions of the late Oliver Braddick, an absolute pioneer in infant vision research, closely connected to the history of the Child Vision Lab! #CVRS2023

Fascinating talk by the brilliant @GeorgiaMNeuro at the 18th Biennial Meeting of the CVRS on the development of prior-knowledge-guided vision throughout childhood! #CVRS2023

Brilliant talk by @LowVisionNews at at #CVRS2023 on empowering children to measure their own vision! Mike, @TesDekker, @AnnegretNoor, and @petejonze explored the feasibility of self-testing through telemedicine, opening up new possibilities for better accessibility and care!

Roni's (@maimon_roni) excellent talk on "Neural Adaptations in Achromatopsia and It's Implications for Gene Therapy" at the 18th biennial Child Vision Research Society Meeting in London is generating a lot of interest! #CVRS2023

We're thrilled for this week's #CVLTalk featuring @marchimmelberg (NYU)! Join us this Thursday, July 6th at 2pm (UK time) as he presents his fascinating work on linking polar angle asymmetries in visual perception and neural architecture. Please DM us for the Zoom link!

Huge congratulations to our very own @maimon_roni and @Mahtab_Frhb for winning the runner-up Research Excellence Award at the @UCLeye @IooECR! Great job!

Congratulations to our very own Dr Michael Crossland (@LowVisionNews) for being awarded the The Neil Charman Medal for Research by The College of Optometrists for his outstanding patient-centred research into low vision, telerehabilitation and the accessibility of care.

4/ To test this, we combined #fMRI population receptive field (pRF) mapping and psychophysics with silent substitution which allowed for selective stimulation of cones and rods. The following image shows the psychophysics and fMRI cone-selective stimuli used in our study.

3/ Using a novel multimodal approach, we demonstrate for the first time that gene therapy can successfully activate dormant cone-mediated pathways in children with achromatopsia (CNGA3- and CNGB3-associated, 10–15 years).